BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10436301)

  • 1. A plasma cell leukemia patient showing bialleic 14q translocations: t(2;14) and t(11;14).
    Sonoki T; Matsuzaki H; Satterwhite E; Nakazawa N; Hata H; Tucker PW; Taniwaki M; Kuribayashi N; Harada N; Matsuno F; Mitsuya H
    Acta Haematol; 1999; 101(4):197-201. PubMed ID: 10436301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
    Nishida K; Tamura A; Nakazawa N; Ueda Y; Abe T; Matsuda F; Kashima K; Taniwaki M
    Blood; 1997 Jul; 90(2):526-34. PubMed ID: 9226151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light-chain plasma cell myeloma caused by 14q32/IGH translocation and loss of the other allele.
    Nishio Y; Sakai H; Saiki Y; Uchida A; Uemura Y; Matsunawa M; Isobe Y; Kato M; Tomita N; Miura I
    Int J Hematol; 2019 May; 109(5):572-577. PubMed ID: 30887274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myelogenous leukemia with acquired t(11;14)(q13;q32) CCND1-IGH: A case report and literature review.
    Manda-Mapalo MT; Khalili P; Quintana D; Rabinowitz I; Zhang QY
    Cancer Genet; 2016 Oct; 209(10):481-485. PubMed ID: 27810077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).
    Sato K; Sakai H; Kato M; Nishio Y; Tsuruoka Y; Uemura Y; Yokoi S; Saito T; Matsunawa M; Suzuki Y; Isobe Y; Inoue Y; Takahashi M; Miura I
    Int J Hematol; 2015 Jun; 101(6):608-11. PubMed ID: 25633778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma.
    Wlodarska I; Meeus P; Stul M; Thienpont L; Wouters E; Marcelis L; Demuynck H; Rummens JL; Madoe V; Hagemeijer A
    Leukemia; 2004 Oct; 18(10):1705-10. PubMed ID: 15306823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene.
    Komatsu H; Iida S; Yamamoto K; Mikuni C; Nitta M; Takahashi T; Ueda R; Seto M
    Blood; 1994 Aug; 84(4):1226-31. PubMed ID: 8049438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of PRAD1/cyclin D1 in plasma cell leukemia with t(11;14)(q13;q32).
    Shimazaki C; Goto H; Araki S; Tatsumi T; Takahashi R; Hirai H; Kikuta T; Yamagata N; Ashihara E; Inaba T; Fujita N; Suzuki R; Nakagawa M
    Int J Hematol; 1997 Jul; 66(1):111-5. PubMed ID: 9220667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.
    Avet-Loiseau H; Li JY; Facon T; Brigaudeau C; Morineau N; Maloisel F; Rapp MJ; Talmant P; Trimoreau F; Jaccard A; Harousseau JL; Bataille R
    Cancer Res; 1998 Dec; 58(24):5640-5. PubMed ID: 9865713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquisition of a t(11;14)(q13;q32) in clonal evolution in a follicular lymphoma with a t(14;18)(q32;q21) and t(3;22)(q27;q11.2).
    Koduru PR; Chen W; Garcia R; Fuda F
    Cancer Genet; 2015 Jun; 208(6):303-9. PubMed ID: 25953460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. t(14;22)(q32;q11) in non-Hodgkin lymphoma and myeloid leukaemia: molecular cytogenetic investigations.
    Aamot HV; Bjørnslett M; Delabie J; Heim S
    Br J Haematol; 2005 Sep; 130(6):845-51. PubMed ID: 16156854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
    Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
    Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionary sequence of cytogenetic aberrations during the oncogenesis of plasma cell disorders. Direct evidence at single cell level.
    Nagy Z; Kajtár B; Jáksó P; Dávid M; Kosztolányi S; Hermesz J; Kereskai L; Pajor L; Alpár D
    Leuk Res; 2011 Aug; 35(8):1114-6. PubMed ID: 21377730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a t(4;14)(p16;q32) in two cases of lymphoma showing both the immunophenotype of chronic lymphocytic leukemia.
    Bacher U; Haferlach T; Schnittger S; Weiss T; Burkhard O; Bechtel B; Kern W; Haferlach C
    Cancer Genet Cytogenet; 2010 Jul; 200(2):170-4. PubMed ID: 20620602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia.
    Taniwaki M; Nishida K; Takashima T; Nakagawa H; Fujii H; Tamaki T; Shimazaki C; Horiike S; Misawa S; Abe T
    Blood; 1994 Oct; 84(7):2283-90. PubMed ID: 7919347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel cryptic translocations involving IGH in B-cell non-Hodgkin's lymphomas.
    Gozzetti A; Davis EM; Espinosa R; Fernald AA; Anastasi J; Le Beau MM
    Cancer Res; 2002 Oct; 62(19):5523-7. PubMed ID: 12359763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation.
    Seto M; Yamamoto K; Iida S; Akao Y; Utsumi KR; Kubonishi I; Miyoshi I; Ohtsuki T; Yawata Y; Namba M
    Oncogene; 1992 Jul; 7(7):1401-6. PubMed ID: 1535701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGH gene involvement in two cases of acute lymphoblastic leukemia with t(14;14)(q11;q32) identified by sequential R-banding and fluorescence in situ hybridization.
    Liu S; Bo L; Liu X; Li C; Qin S; Wang J
    Cancer Genet Cytogenet; 2004 Jul; 152(2):141-5. PubMed ID: 15262434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse B-cell tumors associated with t(14;19)(q32;q13)/IGH::BCL3 identified by G-banding and fluorescence in situ hybridization.
    Ohno H; Maekawa F; Hayashida M; Nakagawa M; Fukutsuka K; Matsumura M; Takeoka K; Maruyama W; Ukyo N; Sumiyoshi S; Tanaka Y; Haga H
    J Clin Exp Hematop; 2024; 64(1):21-31. PubMed ID: 38538317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediate lymphocytic lymphoma with both t(14;19)(q32.3;q13.1) and t(3;22)(q27;q11.2).
    Nakagawa M; Sugiyama H; Ogawa H; Tone S; Morishita H; Ikeda H; Aozasa K; Taniwaki M; Abe T; Kishimoto T
    Cancer Genet Cytogenet; 1995 Jan; 79(1):89-91. PubMed ID: 7850761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.